Follow
Anne-Charlotte Dubbelman
Anne-Charlotte Dubbelman
Verified email at uu.nl
Title
Cited by
Cited by
Year
Novel technologies for metabolomics: More for less
P Miggiels, B Wouters, GJP van Westen, AC Dubbelman, T Hankemeier
TrAC Trends in Analytical Chemistry 120, 115323, 2019
1342019
Pharmacokinetics and excretion of 14C-lenvatinib in patients with advanced solid tumors or lymphomas
AC Dubbelman, H Rosing, C Nijenhuis, ADR Huitema, ...
Investigational new drugs 33, 233-240, 2015
612015
Pharmacokinetics and Excretion of 14C-Bendamustine in Patients with Relapsed or Refractory Malignancy
AC Dubbelman, H Rosing, M Darwish, D D’Andrea, M Bond, E Hellriegel, ...
Drugs in R&D 13, 17-28, 2013
462013
Development and validation of LC–MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine
AC Dubbelman, M Tibben, H Rosing, A Gebretensae, L Nan, SH Gorman, ...
Journal of Chromatography B 893, 92-100, 2012
402012
Development and validation of LC–MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices
AC Dubbelman, H Rosing, B Thijssen, A Gebretensae, L Lucas, H Chen, ...
Journal of Chromatography B 887, 25-34, 2012
362012
Mass balance study of [14C] eribulin in patients with advanced solid tumors
AC Dubbelman, H Rosing, RS Jansen, M Mergui-Roelvink, ADR Huitema, ...
Drug Metabolism and Disposition 40 (2), 313-321, 2012
302012
Data-independent acquisition for the quantification and identification of metabolites in plasma
T van der Laan, I Boom, J Maliepaard, AC Dubbelman, AC Harms, ...
Metabolites 10 (12), 514, 2020
252020
Mass spectrometric recommendations for Quan/Qual analysis using liquid-chromatography coupled to quadrupole time-of-flight mass spectrometry
AC Dubbelman, F Cuyckens, L Dillen, G Gross, RJ Vreeken, ...
Analytica Chimica Acta 1020, 62-75, 2018
242018
Disposition and metabolism of 14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors
AC Dubbelman, A Upthagrove, JH Beijnen, S Marchetti, E Tan, K Krone, ...
Cancer chemotherapy and pharmacology 70, 653-663, 2012
202012
Systematic evaluation of HILIC stationary phases for global metabolomics of human plasma
F Hosseinkhani, L Huang, AC Dubbelman, F Guled, AC Harms, ...
Metabolites 12 (2), 165, 2022
192022
Metabolite profiling of the multiple tyrosine kinase inhibitor lenvatinib: a cross-species comparison
AC Dubbelman, CM Nijenhuis, RS Jansen, H Rosing, H Mizuo, ...
Investigational new drugs 34, 300-318, 2016
192016
Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry
J Hendrikx, AC Dubbelman, H Rosing, AH Schinkel, JHM Schellens, ...
Rapid Communications in Mass Spectrometry 27 (17), 1925-1934, 2013
192013
Fast LC-ESI-MS/MS analysis and influence of sampling conditions for gut metabolites in plasma and serum
T van der Laan, T Kloots, M Beekman, A Kindt, AC Dubbelman, A Harms, ...
Scientific reports 9 (1), 12370, 2019
162019
Metabolite profiling of bendamustine in urine of cancer patients after administration of [14C] bendamustine
AC Dubbelman, RS Jansen, H Rosing, M Darwish, E Hellriegel, ...
Drug Metabolism and Disposition 40 (7), 1297-1307, 2012
162012
Validation of high-performance liquid chromatography–tandem mass spectrometry assays for the quantification of eribulin (E7389) in various biological matrices
AC Dubbelman, H Rosing, B Thijssen, L Lucas, W Copalu, J Wanders, ...
Journal of Chromatography B 879 (15-16), 1149-1155, 2011
132011
Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity
AC Dubbelman, F Cuyckens, L Dillen, G Gross, T Hankemeier, ...
Journal of Chromatography A 1374, 122-133, 2014
112014
Towards standards for human fecal sample preparation in targeted and untargeted lc-hrms studies
F Hosseinkhani, AC Dubbelman, N Karu, AC Harms, T Hankemeier
Metabolites 11 (6), 364, 2021
102021
High-throughput fractionation coupled to mass spectrometry for improved quantitation in metabolomics
T van Der Laan, AC Dubbelman, K Duisters, A Kindt, AC Harms, ...
Analytical Chemistry 92 (21), 14330-14338, 2020
92020
A MASS BALANCE STUDY OF C-14-LENVATINIB (E7080) IN PATIENTS WITH ADVANCED SOLID TUMOURS OR LYMPHOMAS
AC Dubbelman, H Rosing, M Mergui-Roelvink, A Gupta, D Verbel, ...
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 76 (5), 831-831, 2013
82013
Bioanalytical aspects of clinical mass balance studies in oncology
AC Dubbelman, H Rosing, JHM Schellens, JH Beijnen
Bioanalysis 3 (23), 2637-2655, 2011
82011
The system can't perform the operation now. Try again later.
Articles 1–20